Grants and Contracts Details
Description
HUMAN CLINICAL TRIAL - CONFIDENTIAL
Intrepid Abstract
PI: Susan Smyth, MD, PhD
Sponsor: Cleveland Clinic Foundation
Full Title: Investigating Ticagrelor treatment in Patients with Myocardial Injury post non-cardiac Surgery
This is a Phase 4 study, enrolling approximately 1000 patients at 30 centers in the US. We are anticipating approximately 36 to be enrolled at UK. The target population will be undergoing major, non-cardiac surgery, who have a positive troponin (cardiac marker) following a qualifying surgery will be screened for study entry. Patients who qualify will be randomized to either placebo or Ticagrelor and are expected to be followed clinically for a minimum of 13 months, 12 months planned drug therapy. The purpose is to establish the rate of cardiac events in patients with elevated troponins following major non-cardiac surgery and whether Ticagrelor reduces these events.
Status | Finished |
---|---|
Effective start/end date | 6/1/15 → 7/31/16 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.